This paper proposes a sample entropy (SampEn) based prescribed performance controller (SPPC) for the longitudinal control of a supersonic tailless aircraft subject to model uncertainty and nonlinearity. Considering that SampEn can evaluate the system's stability, a SampEn-based feedback adjust system (SFAS) is developed in this paper. With the help of SFAS, the SPPC could identify the dangerous chattering in the status signal that may lead the aircraft to lose control and make appropriate adjustments to feedback. Besides, the SPPC does not require any accurate model information and only needs to know the rough trend of dynamic functions. Although no adaptive or robust control mechanisms are introduced, the SPPC shows robustness against model uncertainty utilizing the nonlinear error feedback. Compared with traditional prescribed performance control (TPPC), the SPPC achieves better performance and safer flight. The whole control structure is developed through the backstepping technique, and the closed-loop stability is proved. At last, the advance of SPPC is verified via simulation using a high-fidelity tailless aircraft model, and the inner mechanisms of SPPC are further discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.isatra.2022.04.041 | DOI Listing |
JMIR Cardio
January 2025
Department of General Medicine, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Background: High blood pressure (BP) is linked to unhealthy lifestyles, and its treatment includes medications and exercise therapy. Many previous studies have evaluated the effects of exercise on BP improvement; however, exercise requires securing a location, time, and staff, which can be challenging in clinical settings. The antihypertensive effects of dance exercise for patients with hypertension have already been verified, and it has been found that adherence and dropout rates are better compared to other forms of exercise.
View Article and Find Full Text PDFUrogynecology (Phila)
December 2024
From the Division of Urogynecology and Reconstructive Pelvic Surgery at the Women and Infants Hospital, Providence, RI.
Importance: There are limited data to guide practices to reduce surgical site infections following sacral neuromodulation; however, many surgeons prescribe prophylactic postoperative antibiotics after device implantation.
Objective: The aim of the study was to compare the proportion of patients with sacral neuromodulation device-associated surgical site infections after use of prophylactic postoperative antibiotics versus none.
Study Design: This was a multicenter retrospective cohort study of patients undergoing sacral neuromodulation device implantation at 11 institutions from January 2014 to December 2023, comparing outcomes in patients who did versus did not receive prophylactic postoperative antibiotic treatment.
Am J Gastroenterol
December 2024
Department of Gastroenterology and Hepatology, Concord Repatriation General Hospital, Sydney, Australia.
Background/aims: There are spare data on comparative medication efficacy in fistulizing Crohn's disease (FCD), particularly with immunomodulator co-therapy. Persistence is a unique way to assess real-world outcomes.
Methods: The persistence of all dispensed biological agents were analysed from the Australian Pharmaceutical Benefits Scheme (PBS) registry data 2005-2021 for FCD.
J Antimicrob Chemother
December 2024
Department of Virology, Sorbonne Université, INSERM, UMR-S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, 83 Boulevard de l'Hôpital 39, F-75013 Paris, France.
Background: The S147G mutation is associated with high-level resistance to the integrase strand transfer inhibitor (INSTI) elvitegravir. In several poorly documented cases, it was also selected in patients on dolutegravir. Given the widespread use of dolutegravir, further studies of S147G are required.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
School of Biomedical Engineering, ShanghaiTech University, Shanghai, China.
Background: About 50-90% people with dementia would develop behavioral disturbances, namely, behavioral and psychological symptoms of dementia (BPSD). Antipsychotic medications are widely used to control severe BPSD symptoms which suffers serious safety risks. It is challenge for individualized precise prediction of antipsychotic drug doses.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!